TTC14: Potential Drug Target Or Biomarker (G151613)

Target Name: TTC14

NCBI ID: G151613

TTC14

TTC14: Potential Drug Target Or Biomarker

TTC14, also known as TTC14 variant 3, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the TTC family, which consists of four isoforms: TTC14, TTC15, TTC16, and TTC17. The TTC family is thought to play a role in the regulation of various cellular processes, including cell adhesion, migration, and signaling pathways.

One of the key functions of TTC14 is its role in the regulation of cell-cell adhesion. This protein is known to be involved in the formation of tight junctions, which are specialized barriers that mediate communication between cells. TTC14 has been shown to play a role in the regulation of tight junction formation by interacting with the protein Zonblatt.

In addition to its role in cell-cell adhesion, TTC14 is also involved in the regulation of inflammation and immune responses. This protein has been shown to be involved in the regulation of the NF-kappa-B signaling pathway, which is a key pathway that regulates inflammation and immune responses.

TTC14 has also been shown to play a role in the regulation of cell proliferation and apoptosis. This protein has been shown to be involved in the regulation of cell proliferation by interacting with the protein p53. regulation of cell apoptosis, which is the process by which cells undergo programmed cell death.

TTC14 has been shown to be expressed in a variety of tissues and organs, including the brain, heart, and kidneys. This protein is also thought to be involved in the regulation of various cellular processes in these tissues, including the regulation of neurotransmitter release, ion channel function, and blood pressure.

Given its involvement in a variety of cellular processes, TTC14 is a potential drug target or biomarker. For example, drugs that target TTC14 have been shown to have potential therapeutic benefits in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. In addition, the regulation of TTC14 has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

Overall, TTC14 is a protein that is involved in a variety of cellular processes and is potential drug target or biomarker. Further research is needed to fully understand the role of TTC14 in cellular processes and its potential as a therapeutic target or biomarker.

Protein Name: Tetratricopeptide Repeat Domain 14

The "TTC14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TTC14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets